Member Info for potnak

The clock is Tyking. I'm sure the days are getting longer or do they just feel long. Ha ha.

The most amazing thing here that I keep telling my missus is the drug only has to be better than below average (Remdesivir) and If the price is right it'll be ordered by the truckload.

Yes it is. Taken too early and the patient might not produce an immune response. Taken too late and it might be too late.

Yes, I second what SOG said, Citizen. You have been prolific with your research posted here. Can't say I understand it all or even a little. As for SOG's suggestions. The trial design is going to be crucial here. You'd want the immune response to kick and do it's job, as a by-product of that would be antibodies but you also don't want to wait until the immune system is overreacting. The vast amounts of data already collected will probably point to a trigger of when to administer treatment.
Low blood oxygen, fever, age, weight etc.. the list must be endless. I'm hoping that Tim and co already have this figured out.

I mean. It would be silly not to be in this over the weekend. :-)

That's a really good analogy, Silver! Will use that when I give my daily report to the missus. Good way to explain why I didn't sell when I effectively had a quarter of a million pound tied up here a couple of weeks ago. She's started to buy house magazines in anticipation of the 6th number coming in. I'll get a B&Q brochure just in case it doesn't.

Bobbler. Presumably, they need to prove they can supply enough for a trial. Once it goes to market. The recipe will go to the cheapest bidder to mass produce.

Still lots of trading going on, Aber. 3 MM's on 6.8 ask so they are servicing the 10% ers.

Another point I didn't make in my rush was the compound doesn't need to be changed just the rules on how you are allowed to use it. We're selling the rights to use the compound in a way that is stated in the patent.

Yes, RMM I was going to mention that you had said the same but was rushing because a call came in.. It's the most logical and cost-effective way to do it.

We did get one, didn't we? The hedge fund that bought in and sold a few weeks later for a small profit. Bet they wished they'd stayed in now. wouldn't mind betting they have been buying and shorting us at te same time this last few weeks.

People keep talking about funding needed but if TYK2 is all it is cracked up to be, we won't need funding, it will be licenced. Covid\Respiratory has added quite a bit of complexity to any potential deal. At the moment a potential partner can't take respiratory with Immune and they may not want or be able to afford the cost of both. I still think they will split them. I know SOG put an argument across for why that can't currently happen but the indication can be separated in the patents. I'm pretty sure some complex discussions are in motion. The other thing to add is I don't think they will apply for a CTA on 1801 immune until the covid trial has some P1 data. Being the same compound, there might be an argument that the Covid P1 data can be used for Immune P1. Why run two costly P1 trials on the same compound if you can share data between the two. So having said the above. Funding for 1801 immune may not be needed because 1801 covid might be showing promise by then. Needing to fund 1801 immune might mean that 1801 Covid isn't so great. Like I said, it complex but I think the team at SAR have it all in hand and have played a blinder by delaying the 1801 immune CTA.

I guess that's because not many trades of 300k or more are on the order books? Does that make more liquid?

Some clarification from LSE. I posted a link from one of the biggest twitter pumpers out there because they mentioned SAR this morning.

I just had my account suspended because I posted a twitter link.. Reinstated now.

Not sure there is no audit trail. The books have to be balanced even if one 1 trade has been made and you could trace the trade to the broker and terminal it was made from if you wanted. This is the thing about conspiracy and myth. You end up believing the small things but ignore the corruption happening in-plane sight. Think about this. Say the 2.5 million the HNWI put in was 10% of their net worth and say they were given extra data we the private investors are not privy to. Then imagine that my investment in SAR is 10% of my total worth. Why should they get extra data and not me? It's insider dealing under the guise of Institutional investing. I think they chuck the 1 codes in on purpose to keep up the pretence and perpetuate the myth.

just looking at that list. I reckon that no more than 10% of the £120 million has been awarded to date. Is this fund available to take 1801 into trials?

Yes, seen this a few times now but in the interest of balance. The MM's used these tactics to takes SAR from 2 to 9.5p in the space of a couple of weeks. Swings and roundabouts. We need them.

Yes, might be a breakout when the spread tightens again. 6.4 then on to 7p

I've got to be right at some point. ;-)